1. Cytoplasmic maspin expression is a predictor of poor prognosis in patients with lung adenocarcinoma measuring <3 cm
- Author
-
Kunio Araki, Kanae Nosaka, Yuji Taniguchi, Hiroshige Nakamura, Tomohiro Haruki, Yoshihisa Umekita, Tatsushi Shiomi, Yuki Matsuoka, Yuzo Takagi, and Chikako Takeda
- Subjects
Male ,Oncology ,Cytoplasm ,medicine.medical_specialty ,Poor prognosis ,Lung Neoplasms ,Serine Proteinase Inhibitors ,Histology ,Adenocarcinoma of Lung ,Adenocarcinoma ,Pathology and Forensic Medicine ,Internal medicine ,Humans ,Medicine ,In patient ,Clinical significance ,Serpins ,Aged ,Neoplasm Staging ,Lung ,business.industry ,Maspin ,General Medicine ,Middle Aged ,Prognosis ,medicine.disease ,Immunohistochemistry ,medicine.anatomical_structure ,Lymphatic Metastasis ,Female ,business - Abstract
Aims Maspin is known to be a tumour suppressor protein, and few studies focused upon its prognostic significance in patients with small-size lung adenocarcinoma have been reported; however, its clinical significance remains controversial. We explored the prognostic value of maspin with particular reference to its subcellular localization in patients with resected lung adenocarcinoma measuring
- Published
- 2014